This is your chance to take action and explore the latest advance in technology for your hard-to-control AF. A new investigational treatment from ProRhythm™ is now being clinically evaluated. You or someone you know may be eligible to participate in the focusAF clinical research study for this investigational treatment, which may result in blocking the electrical impulses that cause Atrial Fibrillation.